$54.63
-2.05-3.62%
At close: -
$58.63
4.007.32%
After Hours: 6:41 PM EDT
Comments
Loading...
Corcept Therapeutics Stock Guidance | NASDAQ:CORT | Benzinga
Corcept Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/26/2025 | CORT | Corcept Therapeutics | FY | 2025 | — | — | — | $900.00M | $950.00M | $855.08M | Get Alert |
| 10/30/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $675.00M | $700.00M | $661.06M | Get Alert |
| 07/29/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $640.00M | $670.00M | $632.15M | Get Alert |
| 05/01/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $620.00M | $650.00M | $610.64M | Get Alert |
| 02/15/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $600.00M | $630.00M | $531.57M | Get Alert |
| 01/08/2024 | CORT | Corcept Therapeutics | Q4 | 2023 | — | — | — | $135.40M | $135.40M | $127.85M | Get Alert |
| 01/08/2024 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $482.40M | $482.40M | $474.82M | Get Alert |
| 01/08/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $600.00M | $630.00M | $513.85M | Get Alert |
| 11/01/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $470.00M | $480.00M | $465.62M | Get Alert |
| 08/02/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $455.00M | $470.00M | $443.89M | Get Alert |
| 05/03/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $435.00M | $455.00M | $435.73M | Get Alert |
| 02/28/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $430.00M | $450.00M | $434.79M | Get Alert |
| 11/03/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $410.00M | $416.67M | Get Alert |
| 08/03/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $430.00M | $414.43M | Get Alert |
| 05/05/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $430.00M | $413.85M | Get Alert |
| 02/15/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $430.00M | $413.19M | Get Alert |
| 11/03/2021 | CORT | Corcept Therapeutics | FY | 2021 | — | — | — | $365.00M | $375.00M | $371.75M | Get Alert |
| 07/29/2021 | CORT | Corcept Therapeutics | FY | 2021 | — | — | — | $355.00M | $385.00M | $370.69M | Get Alert |
| 05/06/2021 | CORT | Corcept Therapeutics | FY | 2021 | — | — | — | $355.00M | $385.00M | $396.20M | Get Alert |
| 02/23/2021 | CORT | Corcept Therapeutics | FY | 2021 | — | — | — | $375.00M | $405.00M | $398.27M | Get Alert |
| 02/08/2021 | CORT | Corcept Therapeutics | FY | 2021 | — | — | — | $375.00M | $405.00M | $403.17M | Get Alert |
| 02/08/2021 | CORT | Corcept Therapeutics | FY | 2020 | $0.85 | $0.85 | $0.80 | $353.90M | $353.90M | $358.48M | Get Alert |
| 02/08/2021 | CORT | Corcept Therapeutics | Q4 | 2020 | $0.20 | $0.20 | $0.20 | $85.70M | $85.70M | $96.17M | Get Alert |
| 11/03/2020 | CORT | Corcept Therapeutics | FY | 2020 | — | — | — | $355.00M | $365.00M | $366.22M | Get Alert |
| 08/04/2020 | CORT | Corcept Therapeutics | FY | 2020 | — | — | — | $355.00M | $375.00M | $368.27M | Get Alert |
FAQ
What is the most recent guidance for Corcept Therapeutics (CORT)?
The most recent guidance for Corcept Therapeutics (CORT) was reported on February 8, 2021 for the full year 2020. The company provided earnings per share guidance in the range of $0.85 to $0.85, compared to the estimated EPS of $0.80. Additionally, Corcept Therapeutics forecasted revenue between $0.35B and $0.35B for the quarter.
Browse guidance and forecast on all stocks.